Skip to main content
NIH funding notice PA-18-386

mHealth Tools for Individuals with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R01 Clinical Trial Optional)

Closed on January 7, 2021.

Posted
November 21, 2017
Close date
January 7, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,182,950 in first-year total cost, median $591,475.

Most frequent study sections

  1. Biobehavioral Medicine and Health Outcomes Study Section[BMHO]1
  2. Clinical Management in General Care Settings Study Section[CMGC]1

Most frequent institutions

  1. CASE WESTERN RESERVE UNIVERSITY1
  2. WAYNE STATE UNIVERSITY1
Competing awards under PA-18-386 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP).1R01NR019585-01A1STILL, CAROLYN HARMONCASE WESTERN RESERVE UNIVERSITY, OH$719,495CMGC
2021Asthma and Technology in Emerging African American Adults (The ATHENA Project)1R01NR019566-01A1BAPTIST, ALAN P.MACDONELL, KARENWAYNE STATE UNIVERSITY, MI$463,455BMHO

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-18-386: mHealth Tools for Individuals with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R01 Clinical Trial Optional) | ScienceDex | ConductScience